Prelude Therapeutics, Inc. (PRLD)
3.89
+0.01
(+0.26%)
USD |
NASDAQ |
Oct 09, 16:00
3.96
+0.07
(+1.80%)
After-Hours: 20:00
Prelude Therapeutics Cash from Investing (Quarterly) : -65.50M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -65.50M |
| March 31, 2026 | 8.499M |
| December 31, 2025 | -60.34M |
| September 30, 2025 | 40.09M |
| June 30, 2025 | 11.52M |
| March 31, 2025 | 62.19M |
| December 31, 2024 | 22.12M |
| September 30, 2024 | 10.73M |
| June 30, 2024 | 26.12M |
| March 31, 2024 | 31.22M |
| December 31, 2023 | 7.736M |
| September 30, 2023 | 15.04M |
| June 30, 2023 | -75.43M |
| March 31, 2023 | 18.00M |
| Date | Value |
|---|---|
| December 31, 2022 | 1.355M |
| September 30, 2022 | 21.61M |
| June 30, 2022 | 17.18M |
| March 31, 2022 | 41.55M |
| December 31, 2021 | -1.804M |
| September 30, 2021 | -260.63M |
| June 30, 2021 | -0.381M |
| March 31, 2021 | -0.986M |
| December 31, 2020 | -0.329M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | -0.08M |
| December 31, 2019 | -0.199M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Q32 Bio, Inc. | 0.00 |
| Intellia Therapeutics, Inc. | -141.57M |
| Twist Bioscience Corp. | -10.20M |
| Beam Therapeutics, Inc. | -9.875M |
| Revolution Medicines, Inc. | -1.659B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -15.57M |
| Cash from Financing (Quarterly) | 85.82M |
| Free Cash Flow | -33.26M |
| Free Cash Flow Per Share (Quarterly) | -0.1583 |
| Free Cash Flow to Equity (Quarterly) | -15.50M |
| Free Cash Flow to Firm (Quarterly) | -15.57M |
| Free Cash Flow Yield | -10.69% |